tiprankstipranks

Roger Pomerantz Insider Profile

4 Followers
Roger Pomerantz, CEO, Director at ContraFect, holds 99.38K shares in Viracta Therapeutics (Ticker: VIRX), holds 213.98K shares in Seres Therapeutics (Ticker: MCRB), holds 100.00 shares in Rubius Therapeutics (Ticker: RUBY).
tipranks
Roger Pomerantz

Roger Pomerantz
ContraFect (CFRXQ)
CEO, Director

Ranked #82,118 out of 98,624 Corporate Insiders

Profitable Transactions

20%
1 out of 5 Profitable Transactions

Average Return

-24.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$293K
72.24%
27.76%
0.00%
0.00%
A breakdown of Roger Pomerantz's holdings

Insider Roles

Seres Therapeutics
(MCRB)
Director
Viracta Therapeutics
(VIRX)
Director
ContraFect
(CFRXQ)
CEO, Director
Indaptus Therapeutics
(INDP)
Director
Roles that Roger Pomerantz holds in companies

Most Profitable Insider Trade

Stock:
ContraFect
(CFRXQ)
Rating:Informative Buy
Date:Jul 26, 2017 - Jul 26, 2018
Return:+75.20%
The most profitable trade made by Roger Pomerantz

Roger Pomerantz's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ContraFect
Jul 26, 2017
CEO, Director
Informative Buy
992.00
$0.00
Seres Therapeutics
Sep 11, 2018
Director
Uninformative Sell
16.29K
$211.84K
RUBY
Rubius Therapeutics
Jul 23, 2018
Informative Buy
2.30K
$5.70
Indaptus Therapeutics
Director
Viracta Therapeutics
Feb 27, 2024
Director
Uninformative Buy
$81.39K
List of latest transactions for each holding click on a transaction to see Roger Pomerantz's performance on stock

Roger Pomerantz insider profile FAQ

What is the percentage of profitable transactions made by Roger Pomerantz?
The percentage of profitable transactions made by Roger Pomerantz is 20%.
    What is the average return per transaction made by Roger Pomerantz?
    The average return per transaction made by Roger Pomerantz is -24.70%.
      What stocks does Roger Pomerantz hold?
      Roger Pomerantz holds: CFRXQ, MCRB, RUBY, INDP, VIRX stocks.
        What was Roger Pomerantz’s latest transaction?
        Roger Pomerantz latest transaction was an Uninformative Buy of ―.
          What was Roger Pomerantz's most profitable transaction?
          Roger Pomerantz’s most profitable transaction was an Informative Buy of CFRXQ stock on July 26, 2017. The return on the trade was 75.20%.
            What is Roger Pomerantz's role in ContraFect?
            Roger Pomerantz's role in ContraFect is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.